Cargando…
Site-Specific DNA Demethylation as a Potential Target for Cancer Epigenetic Therapy
Aberrant promoter DNA hypermethylation is a typical characteristic of cancer and it is often seen in malignancies. Recent studies showed that regulatory cis-elements found up-stream of many tumor suppressor gene promoter CpG island (CGI) attract DNA methyltransferases (DNMT) that hypermethylates and...
Autor principal: | Neja, Sultan Abda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756105/ https://www.ncbi.nlm.nih.gov/pubmed/35036833 http://dx.doi.org/10.1177/2516865720964808 |
Ejemplares similares
-
Active DNA demethylation—The epigenetic gatekeeper of development, immunity, and cancer
por: Prasad, Rahul, et al.
Publicado: (2020) -
Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas
por: Asano, Naofumi, et al.
Publicado: (2019) -
Oxidative damage to epigenetically methylated sites affects DNA stability, dynamics and enzymatic demethylation
por: Gruber, David R, et al.
Publicado: (2018) -
DNA methylation and demethylation as targets for antipsychotic therapy
por: Guidotti, Alessandro, et al.
Publicado: (2014) -
Targeted DNA Demethylation: Vectors, Effectors and Perspectives
por: Yano, Naohiro, et al.
Publicado: (2023)